Lucid Diagnostics Inc (LUCD)

Form 4 - Statement of changes in beneficial ownership of securities

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire NEW YORK, May...

Form 8-K - Current report

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire NEW...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026

PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 PR Newswire...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form ARS - Annual Report to Security Holders

Form DEF 14A - Other definitive proxy statements

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 PR...

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Form 8-K - Current report

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock PR Newswire NEW...

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report